Bile Duct Cancer Research from Dana-Farber Cancer Institute
3 צפיות
• 06/16/23
0
0
לְשַׁבֵּץ
administrator
מנויים
New treatment options are greatly needed in Bile Duct Cancer (cholangiocarcinoma). New research led by Dana-Farber's James Cleary, MD, PhD in Cancer Discovery finds FGFR2 deletion may predict clinical benefit to molecularly targeted therapy. Video published April 30, 2021.
להראות יותר
תגובות בפייסבוק
SORT BY-
תגובות ראשיות
-
תגובות אחרונות